Oxford Medical Simulation, a provider of immersive clinical simulation technology for healthcare and academic institutions, has secured £5 million in growth financing from Salica Investments to support its expansion and product innovation efforts.
The London-based company said the funding will be used to scale its presence across U.S. health systems and academic institutions, while accelerating development of its platform, including AI-driven clinical scenarios, enhanced learning analytics, and workflow tools. The investment will also support infrastructure expansion to improve the delivery of clinical training at scale.
Founded nearly a decade ago by clinicians, Oxford Medical Simulation focuses on bridging gaps between medical education and real-world clinical performance. Its platform enables healthcare professionals and students to engage in realistic, repeatable training simulations that can be accessed anytime and anywhere. The company emphasizes improving clinical readiness, standardizing training outcomes, and supporting workforce development amid ongoing staffing challenges in healthcare.
The company currently works with hospitals, universities, and health systems across the United States, the United Kingdom, and other international markets. Its simulation platform integrates immersive technology with data-driven insights to help institutions measure performance and improve outcomes.
Salica Investments, a UK-based investment firm, focuses on backing high-growth businesses across Europe through a mix of equity and debt strategies. The firm highlighted Oxford Medical Simulation’s differentiated platform and its role in addressing critical training needs in healthcare and education.
The new funding marks Oxford Medical Simulation’s continued push to expand its global footprint and enhance its technology offerings as demand grows for scalable, effective clinical training solutions.
KEY QUOTES
“This financing allows us to invest confidently in the next phase of OMS. Our partners in US healthcare and academia are focused on outcomes – safer practice, better-prepared staff and more efficient delivery. This growth capital from Salica means we can move faster on exactly those priorities: expanding our breadth and depth of content, deepening our analytics capabilities, and supporting more institutions to transform their training for the new generation of learners.”
Michael Wallace, CEO, Oxford Medical Simulation
“Oxford Medical Simulation is exactly the type of business we look to support. The team has built a differentiated platform, proven at scale, and is working with leading health systems and universities to address a critical need: giving clinicians and students the chance to practise safely. We are delighted to back OMS as they scale their impact across healthcare and education.”
Usman Ali, Partner, Salica Investments
